STEPHY.T.P; SREEJITH. K; DR. BINDU G. Comparison of quality of life (QOL) for patients with breast Cancer receiving adjuvant tac (docetaxel, doxorubicin, Cyclophosphamide) and fac (5-fluorouracil, doxorubicin, Cyclophosphamide) therapy. International Journal of Pharma and Bio Sciences, [S. l.], v. 8, n. 3, p. 373–382, 2017. DOI: 10.22376/ijpbs.2017.8.3.p373-382. Disponível em: https://ijpbs.net/index.php/journal/article/view/6006. Acesso em: 3 sep. 2026.